Allscripts (MDRX) Reports In-Line Q2 EPS, Offers Guidance, Approves $250M Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Allscripts announces second quarter 2018 results
August 2, 2018 4:01 PM EDTReported second quarter growth of 23% in GAAP revenue to $526 million, 25% in non-GAAP revenue to $536 millionSecond quarter GAAP EPS of $0.36, growth of 20% in non-GAAP EPS to $0.18Announces new $250 million stock repurchase authorization Closed acquisition of HealthGrid to expand FollowMyHealth® patient engagement platformClosed sale of OneContent; recognized gain of $178 million
CHICAGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30,... More
